115 related articles for article (PubMed ID: 10808180)
1. DiGeorge anomaly: a comparative study of the clinical and immunologic characteristics of patients positive and negative by fluorescence in situ hybridization.
Kornfeld SJ; Zeffren B; Christodoulou CS; Day NK; Cawkwell G; Good RA
J Allergy Clin Immunol; 2000 May; 105(5):983-7. PubMed ID: 10808180
[TBL] [Abstract][Full Text] [Related]
2. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
[TBL] [Abstract][Full Text] [Related]
3. DiGeorge anomaly in the absence of chromosome 22q11.2 deletion.
Rope AF; Cragun DL; Saal HM; Hopkin RJ
J Pediatr; 2009 Oct; 155(4):560-5. PubMed ID: 19595366
[TBL] [Abstract][Full Text] [Related]
4. [Study on clinical features and fluorescence in situ hybridization detections of 22q11 microdeletion syndrome].
Qin YF; Yang JB; Xie CH; Shao J; Zhao ZY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Jun; 24(3):284-7. PubMed ID: 17557238
[TBL] [Abstract][Full Text] [Related]
5. Selective IgM deficiency and 22q11.2 deletion syndrome.
Kung SJ; Gripp KW; Stephan MJ; Fairchok MP; McGeady SJ
Ann Allergy Asthma Immunol; 2007 Jul; 99(1):87-92. PubMed ID: 17650836
[TBL] [Abstract][Full Text] [Related]
6. Congenital heart defects and chromosomal anomalies including 22q11 microdeletion (CATCH 22).
Soares G; Alvares S; Rocha C; Teixeira MF; Mota MC; Reis MI; Feijó MJ; Lima MR; Pinto MR
Rev Port Cardiol; 2005 Mar; 24(3):349-71. PubMed ID: 15929620
[TBL] [Abstract][Full Text] [Related]
7. Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome.
Herwadkar A; Gennery AR; Moran AS; Haeney MR; Arkwright PD
J Clin Pathol; 2010 Feb; 63(2):151-5. PubMed ID: 20154038
[TBL] [Abstract][Full Text] [Related]
8. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
[TBL] [Abstract][Full Text] [Related]
9. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).
Finocchi A; Di Cesare S; Romiti ML; Capponi C; Rossi P; Carsetti R; Cancrini C
Pediatr Allergy Immunol; 2006 Aug; 17(5):382-8. PubMed ID: 16846458
[TBL] [Abstract][Full Text] [Related]
10. Early development of immunity in diGeorge syndrome.
Sedivá A; Bartůnková J; Zachová R; Poloucková A; Hrusák O; Janda A; Kocárek E; Novotná D; Novotná K; Klein T
Med Sci Monit; 2005 Apr; 11(4):CR182-7. PubMed ID: 15795698
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization.
Demczuk S; Desmaze C; Aikem M; Prieur M; Ledeist F; Sanson M; Rouleau G; Thomas G; Aurias A
Ann Genet; 1994; 37(2):60-5. PubMed ID: 7985979
[TBL] [Abstract][Full Text] [Related]
12. The DiGeorge anomaly (CATCH 22, DiGeorge/velocardiofacial syndrome).
Hong R
Semin Hematol; 1998 Oct; 35(4):282-90. PubMed ID: 9801257
[TBL] [Abstract][Full Text] [Related]
13. Genetic background of congenital conotruncal heart defects--a study of 45 families.
Kwiatkowska J; Wierzba J; Aleszewicz-Baranowska J; Ereciński J
Kardiol Pol; 2007 Jan; 65(1):32-7; discussion 38-9. PubMed ID: 17295158
[TBL] [Abstract][Full Text] [Related]
14. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations.
Alikaşifoğlu M; Malkoç N; Ceviz N; Ozme S; Uludoğan S; Tunçbilek E
Turk J Pediatr; 2000; 42(3):215-8. PubMed ID: 11105620
[TBL] [Abstract][Full Text] [Related]
15. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
Jawad AF; McDonald-Mcginn DM; Zackai E; Sullivan KE
J Pediatr; 2001 Nov; 139(5):715-23. PubMed ID: 11713452
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic variability of deletion 22q11.2. An analysis of 16 observations with special emphasis on the neurological manifestations].
Eirís-Puñal J; Iglesias-Meleiro JM; Blanco-Barca MO; Fuster-Siebert M; Barros-Angueira F; Ansede A; Castro-Gago M
Rev Neurol; 2003 Oct 1-15; 37(7):601-7. PubMed ID: 14582013
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies.
Beauchesne LM; Warnes CA; Connolly HM; Ammash NM; Grogan M; Jalal SM; Michels VV
J Am Coll Cardiol; 2005 Feb; 45(4):595-8. PubMed ID: 15708709
[TBL] [Abstract][Full Text] [Related]
18. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome.
Davis CM; Kancherla VS; Reddy A; Chan W; Yeh HW; Noroski LM; Rosenblatt H; Shearer WT; Chinen J
J Allergy Clin Immunol; 2008 Dec; 122(6):1194-9. PubMed ID: 18789819
[TBL] [Abstract][Full Text] [Related]
19. [DiGeorge syndrome, a review of 52 patients].
Minier F; Carles D; Pelluard F; Alberti EM; Stern L; Saura R
Arch Pediatr; 2005 Mar; 12(3):254-7. PubMed ID: 15734119
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
